Redmile Group, LLC Portfolio Holdings

Redmile Group, LLC

  • $1.53 Billion
  • Q2 2024

Redmile Group, LLC has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $1.53 Billion distributed in 63 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Krystal Biotech, Inc. with a value of $188M, Amicus Therapeutics, Inc. with a value of $105M, Nurix Therapeutics, Inc. with a value of $92.3M, Stoke Therapeutics, Inc. with a value of $63.8M, and Immunome Inc. with a value of $59.2M.

Examining the 13F form we can see an decrease of $1B in the current position value, from $2.54B to 1.53B.

Redmile Group, LLC is based out at San Francisco, CA

Below you can find more details about Redmile Group, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.53 Billion
Healthcare: $1.52 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$4.53B
$188 Million 12.22% of portfolio
1,021,078
Q2 2024 Reduced 32.3%
$3.22B
$105 Million 6.85% of portfolio
10,595,089
Q2 2024 Reduced 20.08%
$1.15B
$92.3 Million 6.02% of portfolio
4,423,616
Q2 2024 Reduced 1.33%
$507M
$63.8 Million 4.16% of portfolio
4,721,054
Q2 2024 Reduced 6.94%
$141M
$59.2 Million 3.86% of portfolio
4,889,554
Q1 2024 Added 26.04%
$380M
$53.5 Million 3.49% of portfolio
4,569,802
Q2 2024 Added 0.4%
$2.74B
$51 Million 3.32% of portfolio
929,506
Q2 2024 Reduced 10.43%
$587M
$50.1 Million 3.26% of portfolio
5,562,096
Q2 2024 Added 49.12%
$229M
$48.3 Million 3.15% of portfolio
15,269,217
Q1 2024 Reduced 0.39%
$2.54B
$47.1 Million 3.07% of portfolio
1,579,275
Q2 2024 Reduced 8.93%
$1.47B
$45.4 Million 2.96% of portfolio
5,453,083
Q2 2024 Reduced 15.06%
$236M
$43.2 Million 2.82% of portfolio
13,169,057
Q4 2023 Added 0.34%
$771M
$40.5 Million 2.64% of portfolio
4,799,973
Q2 2024 Added 21.13%
$1.61B
$39.9 Million 2.6% of portfolio
1,703,061
Q2 2024 Reduced 9.39%
$635M
$38.3 Million 2.5% of portfolio
2,014,296
Q2 2024 Reduced 0.66%
$1.5B
$37.9 Million 2.47% of portfolio
1,614,473
Q2 2024 Reduced 13.14%
$10.6B
$33.5 Million 2.18% of portfolio
595,570
Q2 2024 Reduced 5.83%
$347M
$31.5 Million 2.05% of portfolio
6,427,462
Q2 2024 Added 16.8%
$120B
$30.1 Million 1.96% of portfolio
390,253
Q2 2024 Reduced 30.43%
$1.37B
$26.7 Million 1.74% of portfolio
759,516
Q2 2024 Reduced 17.68%
$1.2B
$26.6 Million 1.73% of portfolio
718,723
Q2 2024 Reduced 19.83%
$364M
$25.4 Million 1.66% of portfolio
8,253,316
Q1 2024 Added 2.77%
$1.54B
$25.2 Million 1.65% of portfolio
552,506
Q1 2024 New
$59.1M
$24.3 Million 1.59% of portfolio
4,036,451
Q2 2024 Reduced 6.7%
$262M
$22.5 Million 1.47% of portfolio
1,073,435
Q2 2024 Reduced 14.9%
$53M
$21.7 Million 1.41% of portfolio
5,615,489
Q1 2024 Reduced 0.08%
$470M
$21.1 Million 1.38% of portfolio
3,072,478
Q1 2024 Added 3.4%
$3.55B
$19 Million 1.24% of portfolio
720,177
Q2 2024 Reduced 25.73%
$179B
$17.7 Million 1.16% of portfolio
39,843
Q2 2024 Added 34.85%
$87.9M
$14.4 Million 0.94% of portfolio
16,380,327
Q4 2023 Added 4.8%
$942M
$13.9 Million 0.91% of portfolio
1,881,501
Q2 2024 Reduced 14.27%
$425M
$14 Million 0.91% of portfolio
1,745,656
Q2 2024 Reduced 22.91%
$139B
$13.4 Million 0.88% of portfolio
39,483
Q2 2024 Reduced 8.7%
$386M
$10.7 Million 0.7% of portfolio
2,074,350
Q1 2024 Added 56.63%
$5.42B
$10.2 Million 0.66% of portfolio
94,405
Q2 2024 Reduced 16.5%
$505M
$10.1 Million 0.66% of portfolio
3,065,714
Q2 2024 Added 112.79%
$1.1B
$9.68 Million 0.63% of portfolio
213,024
Q2 2024 Added 86.31%
$500M
$8.85 Million 0.58% of portfolio
3,031,009
Q3 2022 Reduced 12.69%
$552M
$7.99 Million 0.52% of portfolio
560,971
Q2 2024 Reduced 56.3%
$250M
$7.21 Million 0.47% of portfolio
1,807,704
Q2 2024 Reduced 9.93%
$355M
$7.14 Million 0.47% of portfolio
1,463,406
Q2 2024 Reduced 8.79%
$150M
$6.41 Million 0.42% of portfolio
1,942,555
Q2 2024 Reduced 3.66%
$4.88B
$6.06 Million 0.4% of portfolio
111,867
Q2 2024 Reduced 30.78%
$122M
$5 Million 0.33% of portfolio
2,164,126
Q1 2024 Added 944.45%
$145M
$3.84 Million 0.25% of portfolio
2,108,219
Q2 2024 Reduced 36.28%
$49M
$3.73 Million 0.24% of portfolio
2,074,372
Q1 2023 Reduced 26.34%
$108M
$3.31 Million 0.22% of portfolio
442,826
Q1 2024 Reduced 67.78%
$1.46M
$3.17 Million 0.21% of portfolio
5,107,732
Q2 2024 Reduced 11.25%
$108M
$3.08 Million 0.2% of portfolio
3,077,828
Q2 2024 Reduced 10.82%

Summary

  • Portfolio
  • No. of Stocks 63
  • Current Value $1.53 Billion
  • Prior Value $2.54 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 1 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 34 stocks
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email